Umecrine Cognition

CompanySweden

ROR

Umecrine Cognition develops one asset, in phase 1 (golexanolone in primary biliary cholangitis). Mostly small molecule; based in Sweden.

1
Asset
Furthest stage
Phase 1
1
Trial
1
Signal

Pipeline

1
  • golexanolone

    Antagonizes neurosteroid-mediated enhancement of GABA-A receptor signaling.

    Phase 1, Small molecule, primary biliary cholangitis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals2
  • Similar companies6

Intelligence